StockSwitzerlandNYSE

ADCT

ADC Therapeutics SA

Healthcare · Drug Manufacturers - Specialty & Generic

1.22USD

-0.0800 (-6.15%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 1.22

P/E—

Dvd Ind Yld—

P/B—

P/S2.0

Curr EV/T12M EBITDA-4.1

Mkt Cap (USD)0.2B

Curr EV (USD)0.4B

Per Share Data

EPS T12M-0.67

DPS—

Bk Val Per Sh-1.79

Rev/Sh0.55

Cash/Sh1.72

Curr Shares Out127.7M

FCF/Sh-0.66

Cash Flow Analysis

P/CF-1.6

Curr P/FCF-1.6

CF/NI1.1

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales-121.0%

Eff Interest Rate845.7%

Growth Potential

Dil EPS 1Y Gr30.9%

Cap 1Y Gr9.8%

BPS 1Y Gr29.9%

R&D To Sales97.3%

Retention Rate100.0%

Rev 1Y Gr14.9%

FCF 1Y Gr-13.4%

Assets 1Y Gr0.4%

Profitability

EBITDA-0.1B

EBIT-0.1B

Operating Margin-117.8%

Pretax Margin-115.1%

Net Margin-114.6%

ROA-32.3%

ROE45.3%

ROC-47.2%

Asset Turnover0.28

Structure

Current Ratio3.03

Quick Ratio2.86

Debt/Assets156.8%

Debt/Com Eq-192.0%

Net Debt/EBITDA-1.81

Tot Debt/Capital208.7%

Gross Margin89.4%

EBIT/Int Exp-1.9

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.